세계의 바이오메디컬 텍스타일 시장 보고서(2025년)
Biomedical Textiles Global Market Report 2025
상품코드 : 1821617
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오메디컬 텍스타일 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.4%를 나타내 253억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 소비자의 건강과 웰니스 동향, 세계의 건강에 대비, 군 및 방위용도, 맞춤형 의료의 요구, 원격 의료, 웨어러블 헬스에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 의료기술의 진보, 연구협력, 지속가능한 텍스타일 동향 등이 있습니다.

향후 5년간의 성장률 9.4%라고 하는 예측은 이 시장의 전회 예측으로부터 0.3%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 포르투갈과 중국에서 조달하는 수술용 메쉬와 항균성 원단의 비용을 증가시켜 미국 의료용품을 방해하여 제품 가용성을 낮추고 병원 조달 비용을 증가시킬 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

만성 질환 증가는 바이오메디컬 텍스타일 시장 전망 성장을 가속합니다. 만성 질환은 지속적인 의학적 치료가 필요하며 1년 이상 지속됩니다. 만성 질환 환자가 증가함에 따라 수술 치료가 더욱 중요해졌습니다. 바이오메디컬 텍스타일은 수술 중 상처 폐쇄 및 만성 상처 예방과 같은 만성 질환의 관리에 활용됩니다. 예를 들어 영국 정부 기관인 Office for Health Improvement &Disparities의 보고에 따르면 2023년 상반기 만성 하부 호흡기 질환으로 인한 초과 사망자 수는 3,940명으로 예상 비율에 비해 30% 증가했습니다. 연말까지 이 숫자는 5,363명으로 증가했으며, 전체적으로 22% 증가를 반영했습니다. 따라서 만성 질환의 만연이 바이오메디컬 텍스타일 시장을 견인할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Biomedical textiles refer to fibrous textile constructions crafted from synthetic or natural materials with advanced properties, providing resistance against various elements such as fungi, fire, bacteria, dirt, and water. These textiles serve as medical devices utilized either inside or outside the biological environment to enhance patient health.

The primary product types within biomedical textiles include non-implantable and implantable categories. Non-implantable biomedical textiles are employed for external wound dressings. These substances are applied externally to the body, potentially coming into contact with the skin. They are manufactured using various fabrics, such as non-woven biomedical textiles, woven biomedical textiles, and knitted biomedical textiles, and can be composed of non-biodegradable or biodegradable fibers. Applications span across ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and treatment, and other medical fields. Biomedical textiles find utilization in hospitals, ambulatory centers, clinics, community healthcare, and other end-user settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The biomedical textiles market research report is one of a series of new reports from The Business Research Company that provides biomedical textiles market statistics, including biomedical textiles industry global market size, regional shares, competitors with a biomedical textiles market share, detailed biomedical textiles market segments, market trends and opportunities, and any further data you may need to thrive in the biomedical textiles industry. This biomedical textiles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomedical textiles market size has grown strongly in recent years. It will grow from $16.63 billion in 2024 to $17.69 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to infection control prioritization, global health emergencies, focus on regenerative medicine, prevalence of chronic diseases.

The biomedical textiles market size is expected to see strong growth in the next few years. It will grow to $25.34 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to consumer health and wellness trends, global health preparedness, military and defense applications, personalized medicine needs, telemedicine and wearable health. Major trends in the forecast period include advancements in medical technology, research collaborations, sustainable textiles trend.

The forecast of 9.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. medical supplies by increasing the cost of surgical meshes and antimicrobial fabrics sourced from Portugal and China, thereby reducing product availability and elevating hospital procurement expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is driving growth in the biomedical textiles market moving forward. Chronic diseases require ongoing medical attention and persist for over a year. The rise in chronic disease cases has led to a greater emphasis on surgical procedures. Biomedical textiles are utilized in managing chronic diseases for wound closure during surgeries and to prevent chronic wounds. For example, reports from the Office for Health Improvement & Disparities, a UK government body, indicated that in the first half of 2023, there were 3,940 excess deaths attributed to chronic lower respiratory diseases, representing a 30% increase compared to expected rates. By the end of the year, this figure rose to 5,363, reflecting an overall increase of 22%. Therefore, the growing prevalence of chronic diseases is expected to drive the biomedical textiles market.

The increasing healthcare expenditure is projected to drive growth in the biomedical textiles market in the future. Healthcare expenditure encompasses the total amount spent on healthcare goods and services, including medical equipment, pharmaceuticals, hospital care, physician services, and other healthcare-related costs. This spending directly impacts investments in advanced medical treatments, technologies, and healthcare infrastructure. As healthcare expenditure rises, so does the investment in innovative medical treatments and technologies, which has further increased the demand for specialized biomedical textile materials. For example, a report published by the Office for National Statistics, a UK government department, indicated that between 2022 and 2023, healthcare spending in the UK grew by 5.6%, compared to a growth of 0.9% in 2022. The UK healthcare expenditure was approximately $317.63 billion (£292 billion) in 2023. Therefore, the rising healthcare expenditure is driving the growth of the biomedical textiles market.

In the biomedical textiles market, product innovations emerge as a key trend, with major industry players focusing on research and development to introduce cutting-edge solutions. In March 2022, Fabiosys Innovations launched Fabium, a medical textile utilizing Hi-PAT technology for enhanced efficacy against viruses, bacteria, and fungi. This innovation involves processing raw cotton fabric with proprietary chemical formulas through standard textile equipment. The pursuit of novel products through innovation remains a cornerstone in shaping the dynamics of the biomedical textiles market.

Major companies operating in the biomedical textiles sector are strategically collaborating to introduce smart textile platforms that revolutionize the development of biomedical textiles. These partnerships enable the integration of medicine, wellness, and health benefits into clothing, leveraging the combined expertise of the collaborating entities. In August 2023, Nufabrx partnered with Enventys Partners to launch HealthWear, a groundbreaking smart-textile platform that seamlessly administers topical medications activated by body heat and moisture. This strategic collaboration exemplifies the industry's drive to enhance biomedical textiles through innovative solutions.

Strategic acquisitions are bolstering companies' positions in the biomedical textiles market. In April 2022, Integer acquired Aran Biomedical for $131 million. This acquisition enables Integer to integrate Aran Biomedical's technological expertise and knowledge in biomaterial-focused medical implant products with its industry-leading production scale and delivery methods. Aran Biomedical, based in Ireland, contributes to the advancement of biomedical textiles in the context of medical implant products.

Major companies operating in the biomedical textiles market are Confluent Medical Technologies, Cardinal Health Inc, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Smith & Nephew PLC, Meister & Cie AG, Medline Industries Inc, 3M Company, ATEX Technologies, Integra Life Sciences Corporation, Paul Hartmann AG, BSN Medical GMBH, Elkem ASA, Bally Ribbon Mills, Asahi Kasei Corporation, Freudenberg Medical LLC, Getinge AB, Halyard Health, Kimberly-Clark Corporation, Milliken & Company, Molnlycke Health Care AB, Precision Fabrics Group Inc., Secant Group LLC, Stradis Healthcare, Tietex International Ltd., Trelleborg AB, United Medical Industries Co. Ltd., Vestagen Protective Technologies Inc., W.L. Gore & Associates Inc., Weaving Machinery UK Ltd., Welspun Group, Zimmer Biomet Holdings

North America was the largest region in the biomedical textiles market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomedical textiles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biomedical textiles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biomedical textiles market consists of sales of textiles for sutures & ligatures, vascular implants, soft tissue implants, hard tissue implants and hernia repair. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomedical Textiles Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomedical textiles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biomedical textiles ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomedical textiles market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biomedical Textiles Market Characteristics

3. Biomedical Textiles Market Trends And Strategies

4. Biomedical Textiles Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biomedical Textiles Growth Analysis And Strategic Analysis Framework

6. Biomedical Textiles Market Segmentation

7. Biomedical Textiles Market Regional And Country Analysis

8. Asia-Pacific Biomedical Textiles Market

9. China Biomedical Textiles Market

10. India Biomedical Textiles Market

11. Japan Biomedical Textiles Market

12. Australia Biomedical Textiles Market

13. Indonesia Biomedical Textiles Market

14. South Korea Biomedical Textiles Market

15. Western Europe Biomedical Textiles Market

16. UK Biomedical Textiles Market

17. Germany Biomedical Textiles Market

18. France Biomedical Textiles Market

19. Italy Biomedical Textiles Market

20. Spain Biomedical Textiles Market

21. Eastern Europe Biomedical Textiles Market

22. Russia Biomedical Textiles Market

23. North America Biomedical Textiles Market

24. USA Biomedical Textiles Market

25. Canada Biomedical Textiles Market

26. South America Biomedical Textiles Market

27. Brazil Biomedical Textiles Market

28. Middle East Biomedical Textiles Market

29. Africa Biomedical Textiles Market

30. Biomedical Textiles Market Competitive Landscape And Company Profiles

31. Biomedical Textiles Market Other Major And Innovative Companies

32. Global Biomedical Textiles Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biomedical Textiles Market

34. Recent Developments In The Biomedical Textiles Market

35. Biomedical Textiles Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기